Advertisement

Topics

Latest "BioMarker Strategies LLC" News Stories - Page: 3

13:25 EDT 19th March 2019 | BioPortfolio

Here are the most relevant search results for "BioMarker Strategies LLC" found in our extensive news archives from over 250 global news sources.

More Information about BioMarker Strategies LLC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioMarker Strategies LLC for you to read. Along with our medical data and news we also list BioMarker Strategies LLC Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioMarker Strategies LLC Companies for you to search.

Showing "BioMarker Strategies" News Articles 51–75 of 7,500+

Thursday 14th March 2019

#news #biotech New enzyme boosts ‘CRISPR toolbox’ for disease detection

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New enzyme boosts ‘CRISPR toolbox’ for disease detection .Mammoth Biosciences is harnessing CRISPR to create diagnostic tools that can detect any biomarker containing DNA or RNA, with the … Continue reading →


Does a Restrictive Blood Transfusion Strategy Improve Outcomes in Lower Gastrointestinal Bleeding?

Similar patient outcomes were seen with restrictive and liberal transfusion strategies.

SCC Soft Computer Welcomes SDS Pathology as a New Client

SCC Soft Computer (SCC) announced Specialist Diagnostic Services Pty Ltd (SDS Pathology), as a new client. SDS Pathology, the pathology division of Australian listed healthcare provider, Healius Limited, will be replacing their current system, Ultra (Triple G) with SCC’s Laboratory and Genetics Information Management Systems —including SCC’s...


Novel Therapeutics, Dosing Strategies Offer Hope in Metastatic Pancreatic Cancer

Given the poor prognosis of pancreatic cancer and the steady stream of negative phase III trials, clinicians are facing an uphill battle in the treatment of patients with metastatic pancreatic cancer.

Statement by FDA Commissioner Scott Gottlieb, M.D., on new strategies to modernize clinical trials to advance precision medicine, patient protections and more efficient product development

FDA issues statement on new strategies to modernize clinical trials to advance precision medicine, patient protections and more efficient product development

No End in Sight, Bladder Cancer Drug Shortage Takes a Toll

The immunotherapy BCG is in short supply in the United States. The American Urological Association and other groups have responded with a set of treatment strategies for clinicians, but problems are piling up. Medscape Medical News

Netsmart Welcomes Wendy Hill as First Chief People Officer

Netsmart announced today that Wendy Hill has been named the company’s first chief people officer (CPO). Hill will lead this new function that includes the human resources and associate development organization for the Kansas-headquartered healthcare IT provider. To accelerate the company’s focus on developing a people-first culture and ...

Brain contusion biomarker test becomes 3rd CDRH-qualified MDDT

The FDA's Center for Devices and Radiological Health has qualified the OsiriX CDE Software Module under the Medical Device De -More- 

What keeps corporate power hidden from doctors?

McKee and colleagues draw attention to corporate strategies that serve shareholder interests at the expense of public health.1 These effects are often obscured by sophisticated marketing and public...

Renovia Names Jim O’Connor as General Counsel & Senior Vice President, Strategic Development

Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Jim O’Connor has been promoted to General Counsel & Senior Vice President, Strategic Development, effective immediately. Mr. O’Connor joined Renovia as ...

Insilico Medicine announces partnership with Master Investor

Insilico Medicine a biotechnology company specializing in the application of artificial intelligence for drug discovery, biomarker development, and aging research has announced its second year of partnership with Master Investor at the annual Master Investor Show.

Wednesday 13th March 2019

Cell & Gene Therapy Strategies for Successful BLA Submissions: Best Practices for Phase I to FDA Approval Webinar, March 28, 2019

FALLS CHURCH, Va. (PRWEB) March 14, 2019 Cell & Gene Therapy Strategies for Successful BLA Submissions Best Practices for Phase I to FDA Approval **An FDAnews Webinar** Thursday, March 28, 2019, 1:30 p.m. - 3:00 p.m. EDT http://www.fdanews.com/blasubmissions The FDA predicts...

[Comment] Optimising the continuum of child and adolescent health and development

A little over 15 years ago, some of us produced a Lancet Series of papers on child survival and what needed to be done to address the 10 million deaths among children younger than 5 years annually.1 The Series, published soon after the launch of the Millennium Development Goals (MDGs), led to concrete actions and increased accountability. The Series and further work highlighted the high proportion...

C-Path, FNIH announce clinical development user's guide for kidney safety biomarkers

(Critical Path Institute (C-Path)) The Critical Path Institute's (C-Path) Predictive Safety Testing Consortium (PSTC) today announced availability of the User's Guide: Kidney Safety Composite Measure Biomarker for Use in Clinical Development.

College drinking intervention strategies need a refresh

(Michigan State University) Peer approval is the best indicator of the tendency for new college students to drink or smoke according to new research from Michigan State University. This new finding is key to help universities address the problems of underage or binge drinking.

Buying and selling cattle can link individual farms to thousands of others per purchase

(University of Exeter) Understanding the complex networks of 'contact chains' between British farms, could help identify potential routes for spread of infections and improve disease control strategies for the cattle industry.

What does a pregnancy protein have to do with geriatric diseases?

Like the potential of embryonic stem cells to curb ageing, researchers are now investigating a powerful protein in the blood of pregnant woman which could be used to find ways to treat and even prevent a wide range of age-related disorders, from Alzheimer’s and arthritis to macular degeneration and heart disease. Pregnancy is a unique physiological state involving biological stresses that promo...

Target Price Increased on Oil & Gas Company 'Poised for Continued Growth'

A Raymond James report provided reasons for the upward revision and detailed areas of potential growth for this Texas-based entity. Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insigh...

Soft drink companies copy tobacco playbook to lure young users

(University of California - San Francisco) Tobacco conglomerates that used colors, flavors and marketing techniques to entice children as future smokers transferred these same strategies to sweetened beverages when they bought food and drink companies starting in 1963, according to a study by researchers at UC San Francisco.

7 Strategies to Maximize a Break without Losing Focus

We reward a productive stretch with a “quick break” that morphs into a two-hour social media sinkhole. Dr. Ellen Hendriksen helps us maximize our breaks and recharge without losing... -- Read more on ScientificAmerican.com

Nimdzi to Conduct Statewide Medical Interpretation Project for California Department of Health Care Services (DHCS)

Nimdzi Insights LLC is launching a comprehensive project to assess current medical interpretation procedures in California, and to recommend ways to improve language services for the state’s Medicaid beneficiaries who speak little or no English. Mandated by the California State Legislature in August 2016, the project marks the initial implementa...

Physicians' Education Resource® to Present Molecular Tumor Board on EGFR Mutation Positive Lung Cancers

This live symposium will be held adjunct to the American Association for Cancer Research’s annual meeting Physicians’ Education Resource® (PER®), a worldwide leader in continuing medical education (CME), will conduct the live CME-accredited activity, Molecular Tumor Board in EGFR Mutation–Positive Lung Cancers: Integrating Clinical Data Into Pa...

Novel #Oncology Drug Discovery Strategies -- http://ow.ly/5itc30o20dT pic.twitter.com/dJUooNnFnb

Novel #Oncology Drug Discovery Strategies -- http://ow.ly/5itc30o20dT  pic.twitter.com/dJUooNnFnb

Structured exposure to NSCLC patient guidelines fosters smoking cessation, biomarker testing

A new clinical trial finds that exposing patients to tailored versions of nationally-recognised treatment guidelines for non-small cell lung cancer (NSCLC) can help drive smoking cessation, testing for potential biomarkers and, for early-stage disease,...

New Product Launch Strategy Engagement Accelerates Revenue by 20% for a Pharma Company | Infiniti Research’s Latest Success Story

A well-known market intelligence company, Infiniti Research, has recently announced the completion of their new product launch strategy engagement for a pharma company. The study highlights how the client was able to successfully launch two new high-profile oncology drugs and drive better


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks